Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-128687
Filing Date
2024-11-19
Accepted
2024-11-19 16:35:28
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rnlx-20240930.htm   iXBRL 10-Q 1688577
2 EX-31.1 rnlx-ex31_1.htm EX-31.1 12294
3 EX-31.2 rnlx-ex31_2.htm EX-31.2 12799
4 EX-32.1 rnlx-ex32_1.htm EX-32.1 7818
5 GRAPHIC img84511371_0.jpg GRAPHIC 17069
  Complete submission text file 0000950170-24-128687.txt   7981328

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240930.xsd EX-101.SCH 1505808
75 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240930_htm.xml XML 1137385
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39387 | Film No.: 241476735
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)